Clinical predictors of SARS‐CoV‐2 neutralizing antibody titers in COVID‐19 convalescents: Implications for convalescent plasma donor recruitment-Reference-Cited by-同舟云学术

Clinical predictors of SARS‐CoV‐2 neutralizing antibody titers in COVID‐19 convalescents: Implications for convalescent plasma donor recruitment

Published:2021-04-20 Issue:1 Volume:107 Page:24-28
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Focosi Daniele¹^ORCID,Franchini Massimo²

Affiliation:

1. North‐Western Tuscany Blood BankPisa University Hospital Pisa Italy

2. Department of Hematology and Transfusion Medicine Carlo Poma Hospital Mantua Italy

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13630

Reference47 articles.

1. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

2. RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID‐19. 15 January. 2021; https://www.recoverytrial.net/news/statement‐from‐the‐recovery‐trial‐chief‐investigators‐15‐january‐2021‐recovery‐trial‐closes‐recruitment‐to‐convalescent‐plasma‐treatment‐for‐patients‐hospitalised‐with‐covid‐19. Accessed Feb 5 2021.

3. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

4. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

5. Timing of convalescent plasma administration and 28‐day mortality for COVID‐19 pneumonia;Gonzalez SE;medRxiv,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidentally detected West Nile virus‐RNA positive blood donors do not harbor high titers of neutralizing antibodies;Transfusion;2024-08

2. COVID-19 therapeutics;Clinical Microbiology Reviews;2024-06-13

3. The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review;Life;2023-12-11

5. Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China;Frontiers in Immunology;2023-06-14